2017 Departmental Research Summit

Matthew M. Clark, Ph.D., L.P., Chair of Research

Simon Kung, M.D. Co-Chair of Research

Julie Smith and Lori Solmonson, Research Secretaries

Speaker #1: Arya Shah

Presentation: Medical Cannabis Use Among Patients in An Interdisciplinary Pain Rehabilitation Program:  Characterization and Treatment Outcomes

Bio:  Arya is a current third year medical student here at Mayo. She hopes to pursue a career in child and adolescent psychiatry. Her interests outside of medicine include yoga, watercolors and creative writing.

Speaker #2: Allison Holgerson, Ph.D.

Presentation:  Impact of Adverse Childhood Experiences on Risk for Food Addiction and Substance Use in Obesity Treatment-Seeking Individuals

Bio: Dr. Allison Holgerson is a postdoctoral fellow in clinical health psychology, with a major emphasis in weight management. She was awarded her B.S. in Psychology from the University of Florida and her M.S. from Virginia Commonwealth University. Dr. Holgerson completed a Predoctoral Psychology Internship at the University of Florida Health Science Center and received her PhD from Virginia Commonwealth University in 2016. Dr. Holgerson’s primary clinical and research interests are focused in the psychological factors associated with obesity and its treatment, and the assessment and treatment of binge eating disorder and food addiction.

Speaker #3:  Reem Shafi, M.B.B.S.

Presentation:  Daily Right Unilateral Ultrabrief Electroconvulsive Therapy (ECT) Improves Depression Faster Than Bitemporal ECT

Bio:  Dr Reem Shafi completed her BSc and medical training at St. George's University of London, graduating with a Distinction in Clinical Science and Practice. She has practiced as a physician in the UK, Australia and USA.

Speaker #4:   Charles Lewis, M.D.

Presentation:  Cortical Inhibitory Markers of Suicidality in Depressed Adolescents

Bio:  Dr. Lewis graduated from Rice University with a Bachelor of Arts in Psychology in 2005 and from the University of Texas Medical School at Houston with a Doctor of Medicine in 2010.  He completed residency and fellowship training in Psychiatry (2014) and Child and Adolescent Psychiatry (2016) at the Mayo School of Graduate Medical Education, where he served as Chief Resident and was a member of the residency’s research track.  Dr. Lewis currently is a fellow in the MSGME’s Clinician–Investigator Training Program, where he is pursuing several research projects utilizing neuromodulation techniques for therapeutic applications and biomarker development in children and adolescents with mood disorders and suicidality. 

Speaker #5:  Tyler Owens, Ph.D. L.P.

Presentation:  Assessing the Spectrum on Non-Language Cognitive Deficits in Logopenic Aphasia

Bio: Dr. Owens is currently a second year fellow in Adult Neuropsychology in the Department of Psychiatry and Psychology at Mayo Clinic in Rochester, Minnesota. He received his doctorate in Clinical Psychology with a health psychology emphasis from the University of Kansas in Lawrence, Kansas  His research interests include reading difficulties in Primary Progressive Aphasia variants and neuropsychological classification of logopenic aphasia.

Speaker #6:  Leah Grengs

Presentation:  Improvement of Functional Neurologic (Non-Epileptic) Spells with Successful Treatment of Migraine

Bio:  Leah Grengs is a fourth year medical student at Mayo Clinic School of Medicine in Rochester, MN. Prior to Mayo, she studied Anthropology and Neuroscience at the University of Minnesota. Next year, she will continue her training in psychiatry at the University of North Dakota psychiatry residency program.

Speaker #7:  J. Blair Price

Presentation: Metformin Enhances Antidepressant Response Rate to Ketamine in a Rodent Model of Antidepressant Treatment Resistance

Bio:  Being a graduate student in the School of Medicine at Deakin University, much of my work is built collaborations with principle investigators within the Mayo Clinic, Karolinska Institutet, and the University of Minnesota. Much of my research involves ketamine’s antidepressant activity, neuroimaging, treatment resistance, biomarker identification research, mechanisms and neural systems of depression, neuroinflammation, kynurenine metabolism, and deep brain stimulation. My primary focus is the examination of stress systems through the use of ketamine in preclinical models of treatment-resistant depression and through the identification of biomarkers of kynurenine metabolism and mTOR activation. The goal of this is to provide further preclinical and clinical research toward the development of novel pharmacological treatment options designed to be effective in treatment-resistant contexts.

Speaker #8:  Matej Markota, M.D.

Presentation: Mortality in Youth with Positive Urine Drug Screens/Child and Adolescent Psychiatry

Bio:  Dr. Markota grew up in Ljubljana, Slovenia; which is where he graduated from the Faculty of Medicine at the University of Ljubljana. He then spent approximately 4 years doing postmortem studies as a Research Fellow at  the Harvard Medical School, where he published 5 peer-reviewed papers, one of which was on the list of the most cited papers in the Schizophrenia Research journal last year. During this time he also won the 2012 Livingston Award, and the 2014 Neal Alan Mysell Award from the Harvard Medical School for his research work. He is currently a PGY2 in Psychiatry at the Mayo Clinic in Rochester.

Learning Objectives

1. Describe how to complete a research project in the Department of Psychiatry & Psychology.
2. Explain the range of professionals that can be part of a research team.
3. Describe how to present findings of a study in approximately five minutes.  

 
Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu.

Credit Statements
• Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
• Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.
• Archived webcast available at: Psychiatry & Psychology Video Library
Industry Acknowledgment (if applicable): None.

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.
 
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry: 
None

No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, Ph.D., Patricia Maus, M.D., Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Charlene Nelson

Speaker:  See Above Speakers

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None